Clinics and Research in Hepatology and Gastroenterology
Original articleEvaluation of vitamin D status bone mineral density and dental health in children with cholestasis
Introduction
Cholestasis could be defined as a pathological condition of decreased bile formation or flow, in which normally excreted substances into bile are retained including conjugated bilirubin and bile salts which are the commonly measured substances [1].
Irrespective of causes, cholestasis, which is accompanied with hepatic insufficiency additionally, increases malnutrition (increased metabolism, anorexia, vomiting, diarrhea, impaired gastrointestinal absorption of lipids and vitamins A, D, E and K) [2].
Vitamin D which is necessary for bone metabolism is converted in the liver into 25-hydroxyvitamin D (25[OH] D) and then converted into 1, 25-dihydroxy vitamin D in the kidney in order to be metabolically active. So, liver and kidney play vital roles in vitamin D activation [3].
One of the most significant extrahepatic expression of chronic cholestatic liver disease is hepatic osteodystrophy and denotes the ending result of several mechanisms leading to bone fragility [4]. Hepatic osteodystrophy is caused by calcium and vitamin D malabsorption, producing secondary hyperparathyroidism and osteomalacia or rickets [5]. The etiopathogeny of hepatic osteodystrophy is not completely understood [6].
It has been indicated over years that the main bone disorder in chronic hepatic dysfunction is loss of bone mass. Some studies denoted the association of 25-hydroxyvitamin D deficiency and bone disorders in chronic cholestatic liver disease (CCLD) patients due to the significant role of the liver in vitamin D metabolism [7]. The development bone mass is impaired in cholestatic children even in the early stage of chronic cholestatic disease (CCD) [8].
Low bone mineral density, osteopenia and high incidence of fractures in children with cholestatic liver diseases have been denoted by previous finding [3]. The overall objectives of bone densitometry are to detect patients at highest risk of skeletal fragility fractures, to guide decisions concerning management, and to monitor responses to therapy. It is recommended to do skeletal assessments for children with frequent fractures, bony pain or deformities, or osteopenia on regular radiographs or to monitor treatment [9].
Dual-energy X-ray absorptiometry (DXA) has been recognized as a significant device for comprehensive skeletal assessment of children and teenagers but not yet of infants [10].
Studies revealed that a few months after liver transplantation for children with osteopaenia due to CCLD they showed an increase of bone loss; nevertheless, in the long-standing follow-up, these children present a significant increase in bone mineral density (BMD). These data denote the effect of cholestatic disorders on bone mass loss and the significance of normal hepatic function for bone mass gain in CCLD patients [11].
Opacity and hypoplasia of enamel and greenish brown hyperpigmentation of teeth caused by accumulation of biliverdin in dental tissues are odontogenic manifestations of cholestasis [2].
The development of the masticatory system, including odontogenesis is affected by systemic disorders caused by CLD leading to dental hypomineralization of the enamel [12].
In developing countries there is insufficient data regarding serum level of vitamin D and bone affection in cholestatic children and their correlation with laboratory parameters.
Section snippets
Aim of work
The aim of this study was to evaluate the dental and BMD and the serum level of vitamin D in cholestatic infants and children and to correlate this process with clinical laboratory parameters.
Patients and methods
This is a cross-sectional study that include 50 patients presenting with cholestasis. Patients were recruited from the hepatology outpatient clinic at Cairo University Pediatric Hospital and the National Hepatology and Tropical Medicine Research Institute (NHTMRI). The study also included 30 age- and sex-matched controls. The protocol was approved by the Faculty of Medicine Research Ethics Committee. Assent of the children and consent was obtained after proper orientation of the care givers
Results
Out of the 50 cholestatic cases; 23 were females (46%); the mean age of the cases was 6.17 ± 3.9 years SD ranging from 1.1 year to 17 years. Both cases and controls were age and sex matched.
Progressive familial intrahepatic cholestasis (PFIC) is the most frequent cause (40%) followed by biliary atresia operated upon by Kasai surgery unfortunately with unsuccessful one (12%). It is to be noted that we could not reach a definitive diagnosis in 12% of the studied cases.
Regarding bone and dental
Discussion
Deficiency of vitamin D is extremely predominant in children with CLD and its severity is inversely related to the levels of vitamin D [17].
In the current study the mean serum level of vitamin D was 37.9 ng/mL in cases and hypovitaminosis D was observed in 28 (56%) of cases [15 (30%) with deficient level and 13 (26%) with insufficient level]. Mohammadi et al. [18] found hypovitaminosis D in 64.5% in children with cholestatic liver diseases [10.4% with deficiency and 54.1% with insufficiency]
Conclusion
Decreased level of 25-OH vitamin D is present in more than half of cholestatic patients, and is correlated positively to serum calcium. Decreased BMD was correlated to the low serum calcium rather than the vitamin D level. The decreased BMD in cholestatic children is related to the level of hyperbilirubinemia.
Authors contribution
Shaimaa Emad El Abrak: contributed to the conception and design of the study, analysis and interpretation of data and drafting the article.
Hanaa H. EL Dash, Mona El Said EL Raziky: contributed to the conception and design of the study, analysis and interpretation of data and drafting and revising the article.
Nashwa M. Samra, Manal A. Elsheikh: contributed to the conception and design of the study, acquisition and interpretation of data and revising the article. All authors have approved the
Funding sources
This research did not receive any specific grant from any funding agencies in the public, commercial, or not-for-profit sectors.
Disclosure of interest
The authors declare that they have no competing interest.
References (43)
- et al.
Vitamin D and parathyroid hormone in outpatients with non-cholestatic chronic liver disease
Clin Gastroenterol Hepatol
(2007) - et al.
American Gastroenterological Association (AGA) technical review on osteoporosis in hepatic disorders
Gastroenterology
(2003) - et al.
Dual-energy x-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD pediatric official positions
J Clin Densitom
(2008) - et al.
Bone mineral density in long term survivors following pediatric liver transplantation
Liver Transpl
(2003) - et al.
The nature of malnutrition in children with end-stage liver disease awaiting orthotopic liver transplantation
Am J Clin Nutr
(1992) - et al.
Effect of childhood malnutrition on salivary flow and pH
Arch Oral Biol
(2008) - et al.
Management of children with hyperbilirubinemia and green teeth
J Pediatr
(1986) - et al.
Prevalence of subclinical vitamin K deficiency in cholestatic liver disease
J Pediatr Gastroenterol Nutr
(2009) - et al.
Liver diseases and metabolic syndrome
J Gastroenterol
(2008) Cholestasis and metabolic bone disease – a clinical review
Wien Med Wochenschr
(2008)
Studies on dental caries I dental status and dental needs of alimentary school children
Public Health Rep
Bone disorders in chronic liver disease
Hepatology
Impairment of bone mass development in children with chronic cholestatic liver disease
Clin Endocrinol
Protein-energy malnutrition and early childhood caries
Rev Nutr
Normal serum vitamin D levels
N Engl J Med
2008 Official positions of the International Society for Clinical Densitometry and Executive Summary of the ISCD Pediatric Position Development Conference
J Clin Densitom
Bone densitometry in children and adolescents. Pediatrics
Am Acad Pediatr
Transection of the oesophagus for bleeding oesophageal varices
Br J Surg
Vitamin D in chronic liver disease
Liver Int
Prevalence of vitamin D deficiency and rickets in children with cholestasis in Iran
Acta Medica Iranica
Cited by (19)
Fat Soluble Vitamin Assessment and Supplementation in Cholestasis
2022, Clinics in Liver DiseaseCitation Excerpt :Clearance of jaundice before 3 months was inversely related to rickets.33 In a study of cholestatic children in Egypt, 28 of 50 (mean age 6 years) had rickets, while 7 had one or more fractures and 30% of those had serum 25-OHD levels less than 20 ng/ml.34 In addition to rickets and fractures, cholestatic patients are at risk for reduced bone mass as assessed by quantitative measures such as dual x-ray absorptiometry (DXA).
Daily Vitamin D Supplementation Improves Vitamin D Deficiency in Patients With Chronic Liver Disease
2023, Journal of Pediatric Gastroenterology and Nutrition